MPN Case Discussion: ET With Coincindent CLL

Forgot your password?

Select specialty

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

September 27, 2024

Feat. H. Erba

West Oncology Conference

Sat, Feb 8, 2025

Danielle Brander

Louisville Hematology Highlights

Indy Hematology Review

Integrity CE

M. Cortese, D. Wallace, A. Niu

Indy Hematology Review

SOHO Brazil 2024

Yale Cancer Center

N. Podoltsev

Integrity CE

Nicole Lamanna

XV Eurasian Hematology-Oncology Congress - EHOC 2024

16th International Congress on Myeloproliferative Neoplasms

City of Hope

Feat. C. Harrison

Massachusetts General Hospital Cancer Center

Indy Hematology Review

University of Colorado Division of Hematology

2024 ASH Annual Meeting Insights Hub

J. Kiladjian

Feat. C. Harrison

16th International Congress on Myeloproliferative Neoplasms

N. Pemmaraju

Login

Login

Join VuMedi

MPN Case Discussion: ET With Coincindent CLL

62-Year-Old Male: Elevated Platelet Count & Diagnosis

Essential Thrombocythemia Treatment Plan & MAJIC-ET Study

New Findings: Rise in Total Count & Absolute Lymphocytosis

Co-occurrence of MPN & LPDs: Systemic Reviews & Diagnosis

CLL Patient Staging & Low-Risk Prognosis

CLL Treatment Plan & Case Report Comparisons

Importance of Early Management of Patients with Myelofibrosis (MF)

A proven CD123 targeted therapy for BPDCN

Related Videos

West Oncology Conference

Choosing BTKi or BCL2i or Combination Therapy for 1L CLL

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Clinical Practice Updates in CLL/SLL

Current Approaches in the Treatment of Myeloproliferative Neoplasms

1L Therapy in CLL: What Are the Best Options?

Myeloid Malignancies: Hot Topics in 2024

2024 Updates on Myeloproliferative Neoplasms, PV, and ET

Sequencing Therapies in CLL: The Importance of First-Line Treatment …

Optimizing the Management of Patients with Polycythemia Vera (PV)

Debates in CLL: Continuous or Finite Duration Therapy

Allele Burden in MPN: Practical Considerations

CLL Treatment Sequencing: The Importance of First Choice

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Practice-Changing Updates in Indolent B-Cell Lymphomas

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

2024 Updates in PV/ET

ASH 2024 Summary: Pegylated Interferon in MPN - The Who, Why, and How

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Novel Agents for MPNs in 2024